ABEO ABEONA THERAPEUTICS INC.

8-K Current Report

Filed: March 17, 2026

Health Care

Pharmaceutical Preparations

ABEONA THERAPEUTICS INC. (ABEO) 8-K current report filed with SEC EDGAR on March 17, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

• Q1 2025 earnings results disclosed via press release exhibit — refer to Exhibit 99.1 for actual financial figures
• Filing structured to limit legal liability under Exchange Act Section 18 — standard earnings release protective language

+1 more insights

Other ABEONA THERAPEUTICS INC. 8-K Filings

8-K Mar 9, 2026

Get deeper insights on ABEONA THERAPEUTICS INC.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.